CADL: Candel Therapeutics, Inc. Stock

by  •  • Comments Off on CADL: Candel Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 216.45
Enterprise Value ($M) 214.81
Book Value ($M) -15.26
Book Value / Share -0.47
Price / Book -14.19
NCAV ($M) -18.69
NCAV / Share -0.58
Price / NCAV -11.58

Profitability (mra)
Return on Invested Capital (ROIC) -68.14
Return on Assets (ROA) -1.27
Return on Equity (ROE) -4.10

Liquidity (mrq)
Quick Ratio 1.18
Current Ratio 1.18

Balance Sheet (mrq) ($M)
Current Assets 18.09
Assets 21.52
Liabilities 36.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-17 13G CVI Investments, Inc. 5.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-25 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT P
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 243,337 962,341 25.29
2025-01-17 580,086 1,828,436 31.73
2025-01-16 179,337 1,163,878 15.41

(click for more detail)

Similar Companies
BCAB – BioAtla, Inc. BHST – BioHarvest Sciences Inc.
BTMD – biote Corp. CARM – Carisma Therapeutics, Inc.
CGTX – Cognition Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io